| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |